| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: | 5213 | 3178 | 2332 |
 | EY Pythagoras This page is no longer being updated. We are now EY Pythagoras. Follow the EY LinkedIn page here: https://www.linkedin.com/company/ernstandyoung/ to keep up to date with our news, events and technical consulting offerings. CRM, Microsoft Dynamics 365 Consultancy, training, support, SharePoint, SharePoint Consultancy, training, support, Office 365, Office 365 Consultancy, training, support, Yammer, Power BI, Microsoft Dynamics 365, Azure, Power Apps, and Power Platform | 8270 | 6773 | 3278 |
 | Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, … Sectors: | 391 | 335 | 58 |
 | PULSALYS [Automatic translation follows] Incubates Deep Tech startups & accelerates scientific innovations from the R&D labs of Lyon-St Etienne 🚀 PULSALYS, the Deep Tech innovation incubator and accelerator of Lyon & St Etienne, builds the innovative products & services of tomorrow, by transforming scientific discoveries from the laboratories of the University of Lyon into economic opportunities for companies and startups. Created in December 2013 as part of the Future Investment Program (PIA) under the status of Technology Transfer Acceleration Company (SATT), PULSALYS has become a key player in the attractiveness and economic development of the Lyon - St-Etienne region. Chemistry & … Tags: SATT Network Sectors: | 424 | 123 | 349 |
 | SATT CONECTUS La recherche publique a mille talents. Profitez-en pour innover ! Welcome :) #tech #deeptech #innovation #eastoffrance Trait d’union entre la recherche publique alsacienne et les entreprises, la SATT Conectus conduit les inventions qui naissent au cœur des laboratoires jusqu’au marché. Elle protège leurs découvertes, finance et accompagne les projets prometteurs jusqu’à leur adoption par les industriels et/ou investisseur, en portant le risque technologique et financier. Conectus est également opérateur pour le compte de la majorité de ses actionnaires de la mise en œuvre des partenariats Chercheurs / Entreprises. ----------- SATT* Conectus Alsace is the main entry point for business partners … Tags: SATT Network Sectors: | 310 | 73 | 154 |
 | Kurma Partners Our Vision : We have High Standards - We Build Companies - We have Impact Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2). Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech Sectors: | 141 | 91 | 36 |
 | Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: | 12301 | 9342 | 1576 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3486 | 2601 | 833 |
 | Seventure Partners We actively fund innovative companies within the two evolving fields of Digital technologies and Life sciences. Seventure Partners is a long term equity investor that actively supports innovative companies aiming at generating positive impacts on Humankind, Society, Sustainability and the Planet. With €950m net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe investing since 1997 in innovative businesses with high growth potential in 2 main areas: Life sciences (Biotech, Health & digital Health, Nutrition, Foodtech, Blue Economy, Aquaculture, Animal & Agriculture, Sport & Wellness ...) with a specific interest for … Sectors: | 292 | 174 | 95 |
 | Région Ile de France The Paris Region is a major business and techno hub in Europe. Standing at the crossroads of European and worldwide trade, the Paris Region is France's leading economic region. It represents 31% of French GDP. Consisting of 8 départements and 1,280 municipalities, the Paris Region hosts the largest population of french Regions : 12.5 million inhabitants, that is younger than the national average. As Europe’s leading employment area, it boasts a highly qualified workforce : 33% of French executives. The Paris Region hosts 22% of France’s universities, 25% of its engineering schooland 20% of its business schools. Invest in Paris … Sectors: | 4879 | 4011 | 690 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: | 629 | 381 | 382 |
 | Atlanpole Biotherapies Thinking up tomorrow's medicine Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com Biotechnologies, Bioproduction, Pharma, Technologies médicales innovantes, MedTech, Numérique pour la santé, … Sectors: | 313 | 124 | 205 |
 | Genopole Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy Sectors: | 316 | 162 | 160 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1568 | 1425 | 60 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: | 806 | 622 | 70 |
 | Syneos Health Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment. Clinical Trials and Biopharmaceutical Product Lifecycle Management Sectors: | 140 | 124 | 20 |
 | Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: | 598 | 332 | 75 |
 | Regeneron At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An … Sectors: | 361 | 275 | 23 |
 | Novo Nordisk Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: | 1360 | 1110 | 144 |
 | Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: | 1761 | 1567 | 123 |
 | Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: | 702 | 551 | 84 |
 | McKinsey & Company We accelerate sustainable and inclusive growth. McKinsey & Company is a global management consulting firm. We are the trusted advisor to the world's leading businesses, governments, and institutions. We work with leading organizations across the private, public and social sectors. Our scale, scope, and knowledge allow us to address problems that no one else can. We have deep functional and industry expertise as well as breadth of geographical reach. We are passionate about taking on immense challenges that matter to our clients and, often, to the world. We work with our clients as we do with our colleagues. We build … Sectors: | 4750 | 4039 | 673 |
 | Deutsche Börse As one of the world’s leading exchange organisations, Deutsche Börse Group provides investors, financial institutions and companies access to global capital markets. Our business covers the entire financial market transaction process chain, ranging from securities and derivatives trading, clearing, settlement and custody, to market data and the development and operation of electronic trading systems. As a technology company, we develop state-of-the-art IT solutions and offer IT systems all over the world. Our reliable systems and our integrity as a neutral market infrastructure provider form the basis of our business philosophy. We operate to the most exacting standards to create products … | 618 | 357 | 259 |
 | AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: | 3790 | 2621 | 203 |
 | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: | 1621 | 945 | 333 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: | 264 | 188 | 35 |
 | AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: | 941 | 772 | 130 |
 | Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: | 1487 | 870 | 336 |
 | MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: | 2108 | 1856 | 189 |
 | Financial Times About the Financial Times The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community. Learn more about the FT, including announcements and career opportunities, at aboutus.ft.com. Subscribe at subs.ft.com. One of the world’s leading business news organisations Sectors: | 10647 | 9398 | 476 |
 | Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: | 699 | 485 | 49 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: | 4533 | 2894 | 644 |
 | UK Export Finance We help UK companies of all sizes win contracts, fulfil orders and get paid. UK Export Finance is the UK’s export credit agency and a government department, working alongside the Department for Business and Trade as an integral part of its strategy and operations. Our mission is to advance prosperity by ensuring no viable UK export fails for lack of finance or insurance, doing that sustainably and at no net cost to the taxpayer. We help UK companies of all sizes and in all sectors win, fulfil and get paid for export contracts. Export finance and insurance Sectors: | 3582 | 2700 | 447 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: | 1886 | 1267 | 258 |
 | Eurostat High quality statistics and data on Europe. Lawful good. EUROSTAT is the statistical office of the European Union. Our mission is to provide high quality statistics and data on Europe. Our values: Show respect for our staff, partners and users Strive for excellence in everything we do Drive innovation in official statistics Promote service orientation Uphold professional independence ESS partnership Eurostat produces European statistics in partnership with National Statistical Institutes and other national authorities in the EU Member States. This partnership is known as the European Statistical System (ESS). It also includes the statistical authorities of the European Economic Area … Sectors: | 10373 | 7449 | 1325 |
 | Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: | 984 | 700 | 263 |
 | Amazon Web Services (AWS) Official Global LinkedIn page for Amazon Web Services (AWS). Launched in 2006, Amazon Web Services (AWS) began exposing key infrastructure services to businesses in the form of web services -- now widely known as cloud computing. The ultimate benefit of cloud computing, and AWS, is the ability to leverage a new business model and turn capital infrastructure expenses into variable costs. Businesses no longer need to plan and procure servers and other IT resources weeks or months in advance. Using AWS, businesses can take advantage of Amazon's expertise and economies of scale to access resources when their business needs them, … Sectors: | 7455 | 6756 | 139 |
 | Google A problem isn't truly solved until it's solved for all. Googlers build products that help create opportunities for everyone, whether down the street or across the globe. Bring your insight, imagination and a healthy disregard for the impossible. Bring everything that makes you unique. Together, we can build for everyone. Check out our career opportunities at goo.gle/3DLEokh search, ads, mobile, android, online video, apps, machine learning, virtual reality, cloud, hardware, artificial intelligence, youtube, and software Sectors: | 25445 | 19871 | 1089 |
 | HTGF | High-Tech Gründerfonds Seed Investor. We invest in People. Venture Capital for High-Tech Founders. Made in Germany. HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more … | 892 | 461 | 506 |
 | Amazon Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. We are driven by the excitement of building technologies, inventing products, and providing services that change lives. We embrace new ways of doing things, make decisions quickly, and are not afraid to fail. We have the scope and capabilities of a large company, and the spirit and heart of a small one. Together, Amazonians research and develop new technologies from Amazon Web Services to Alexa on behalf of our customers: shoppers, sellers, content creators, and developers around the … Sectors: | 20594 | 16193 | 806 |
 | Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: | 4734 | 2898 | 637 |
 | General Electric A new era is here, and we want you to be a part of it. We will now be sharing our content on our respective GE Aerospace and GE Vernova pages. Be sure to follow each to keep up with the future of aviation and energy. Oil & Gas, Healthcare, Intelligent Platforms, Renewable Energy, Transportation, Aviation, Digital, Lighting, Power, and Energy Management Sectors: | 4863 | 3071 | 665 |
 | Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: | 1661 | 1074 | 127 |
 | Plug and Play Tech Center Driving the future forward with corporations, governments, startups, investors, and universities. Plug and Play is the ultimate innovation platform. Our mission is to build the world’s leading innovation platform and make innovation open to anyone, anywhere. We do this by connecting entrepreneurs, corporations, and investors worldwide. Over the past 15 years, we have brought together 35,000+ startups, 500+ world-leading corporations, and hundreds of venture capital firms, universities, and government agencies across 20+ industries. We are active in 50+ locations globally, including the U.S., China, France, Germany, South Africa, Singapore, Indonesia, Brazil, and more. Together with our partners, we are creating … Sectors: | 3557 | 1992 | 646 |
 | IBM At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If you're searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you. We're here to help every creator turn their "what if" into what is. Let's create something that will change everything. Cloud, Mobile, Cognitive, Security, Research, Watson, Analytics, Consulting, Commerce, Experience Design, Internet of Things, Technology support, Industry solutions, Systems services, Resiliency services, Financing, and IT infrastructure Sectors: | 15821 | 10689 | 536 |
National and local authorities